The dichotomy of p53 regulation by noncoding RNAs

9Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The p53 tumor suppressor gene is the most frequently mutated gene in cancer. Significant progress has been made to discern the importance of p53 in coordinating cellular responses to DNA damage, oncogene activation, and other stresses. Noncoding RNAs are RNA molecules functioning without being translated into proteins. In this work, we discuss the dichotomy of p53 regulation by noncoding RNAs with four unconventional questions. First, is overexpression of microRNAs responsible for p53 inactivation in the absence of p53 mutation? Second, are there somatic mutations in the noncoding regions of the p53 gene? Third, is there a germline mutant in the noncoding regions of the p53 gene that predisposes carriers to cancer? Fourth, can p53 activation mediated by a noncoding RNA mutation cause cancer? This work highlights the prominence of noncoding RNAs in p53 dysregulation and tumorigenesis. © 2014 The Author (2014). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS. All rights reserved.

Cite

CITATION STYLE

APA

Deng, Q., Becker, L., Ma, X., Zhong, X., Young, K., Ramos, K., & Li, Y. (2014). The dichotomy of p53 regulation by noncoding RNAs. Journal of Molecular Cell Biology. Oxford University Press. https://doi.org/10.1093/jmcb/mju017

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free